News Releases
 Print Email

Syngenta Biotechnology, Inc., Celebrates 25 Years of Innovation

12/7/2009

  • Syngenta recognizes biotechnology achievements over past 25 years
  • Company continues to expand facility and plan for future growth after quarter century
 
Research Triangle Park, N.C., USA, December 7, 2009 — Syngenta Biotechnology, Inc., (SBI), celebrates its 25th anniversary as a world-class facility for crop genetics research and discovery. SBI, located in Research Triangle Park, N.C., opened its doors in 1984 and since then has expanded into nearly 200,000 square feet of laboratories, offices and greenhouses. The facility serves as the key North American location for plant gene technology research for Syngenta, and employs over 400 staff. 
 
SBI was founded with the principle of delivering innovation in plant biotechnology. Syngenta uses these technologies to develop crops with improved yields which help growers meet their production goals.
 
“SBI remains a leader in developing new products that help farmers meet the demands of a growing global population,” said SBI president and global head of biotechnology R&D Michiel van Lookeren Campagne. “SBI is home to some of the key genetic research milestones in agriculture and continues to combine technology with talent and expertise to create innovative new tools and integrated solutions for growers.”
 
Syngenta is growing its biotechnology research and development operations both in North Carolina and globally. In the past month, SBI has leased 100,000 more square feet of space and signed an agreement to purchase an additional 50 acres of land for potential future expansion.
 
Key milestones that SBI has achieved in the past 25 years include:
  • Bt176, the first genetically modified corn product ever to be sold and planted by U.S. corn growers.
  • Donation of new Golden Rice, which increase pro-Vitamin A levels more than 20-fold over the original Golden Rice, to the Golden Rice Humanitarian Board for developing countries.
  • Invention of MIR604 (marketed as the Agrisure® RW trait), which protects corn from several species of corn rootworm.
  • Stacked combinations of corn traits to protect against corn rootworm and European corn borer, and provide glyphosate and glufosinate tolerance. The double stack is marketed as the Agrisure CB/LL/RW stack and the triple stack is marketed as the Agrisure 3000GT stack.
  • MIR162, a new insect control event in development for corn, which will be marketed as the Agrisure VipteraTM trait following receipt of all regulatory approvals*, contains the Vip3A protein and protects against one of the broadest ranges of lepidopteran corn insect pests to date.
 
In addition to SBI, the sister site, Syngenta Biotechnology China Co. Ltd., was opened in Beijing in early 2008. It is the first foreign-funded agricultural biotech research institution in China, now with more than 70 employees. 
 
In October, Syngenta was named in the top 20 among biotechnology and pharmaceutical employers by Science magazine.
 
Syngenta is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
 
###
Media contacts:
 
Jane Bachmann
Syngenta Biotechnology, Inc. 
919-541-8538 or jane.bachmann@syngenta.com
 
Casey Novak
Gibbs & Soell, Inc. Public Relations
919-870-5718 or cnovak@gibbs-soell.com
 
Related Links:
 
Cautionary Statement Regarding Forward-Looking Statements_____________________________________________
 
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.
Agrisure®,  Agrisure Viptera™ and the Syngenta logo are trademarks of a Syngenta Group Company.